LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Immunomodulatory effect of Celecoxib on HMGB1/TLR4 pathway in a recurrent seizures model in immature rats

Photo from wikipedia

ABSTRACT Epileptic seizures constitute an important problem in pediatric neurology during the developmental period. The frequency and nosological significance of seizures, as well as their association with epileptogenesis, may be… Click to show full abstract

ABSTRACT Epileptic seizures constitute an important problem in pediatric neurology during the developmental period. The frequency and nosological significance of seizures, as well as their association with epileptogenesis, may be related to underlying mechanisms such as neuroinflammation. Those mechanisms of response activate inflammatory molecules induced in the neurons, activated glial cells and endothelial cells via the key HMGB1/TLR4 pathway. In this study, the drug celecoxib (CCX) was used as a blocker of the cyclooxygenase 2 (COX‐2) and HMGB1/TLR‐4 pathways. The experimental model was implemented in 10‐day‐old neonatal Sprague Dawley rats to induce recurrent seizures with kainic acid (KA, 1.4 mg/kg). Data were evaluated at early (14 PND) and late (30 PND) time points. The results showed that the CCX and CCX + pentobarbital (PB) groups exhibited a protective effect by significantly increasing the time latency of seizures compared to the KA group at both early (p < 0.01) and late (p < 0.001) times. When the CCX group was compared to the KA group, there was also a significant decrease in the number of HMGB1 and TLR‐4 transcripts (p < 0.05) and in COX‐2 protein expression (p < 0.05) in the most important areas for seizure generation (the hippocampus and cortex) at both the early and late time points. These results demonstrated that CCX treatment after epileptic seizures has a neuroprotective effect due to the inhibition of proinflammatory proteins and associated signaling pathways and reduces seizure susceptibility. Additionally, the timely intervention of inflammatory pathways will reduce the risk of developing epilepsy in adulthood. Graphical abstract The post‐treatment effect of CCX administration in a KA‐induced seizures immature rats model was assessed in 14 PND and 30 PND animals, through clinical manifestations and expression of the pro‐inflammatory molecules TLR4, HMGB1 and COX‐2 in susceptible brain areas of seizures generation, and at risk of generating epileptogenesis in adulthood. Figure. No caption available. HighlightsKA induces a reproducible convulsive activity in 10 PND Sprague Dawley rats.CCX pos‐treatment has a neuroprotective effect on seizure activityCCX pos‐treatment decreases pro‐inflammatory molecules expression.CCX and PB post‐treatment has a combined effect on proinflammatory molecules.

Keywords: hmgb1; hmgb1 tlr4; treatment; tlr4 pathway; effect; pnd

Journal Title: Pharmacology Biochemistry and Behavior
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.